![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 01, 2021 7:05:51 AM
So author think that August will be a very exciting month for us.
And yes, we are expecting so many things..
...." Super News Circle Coming"..
Brazilian Trial.--
--still show high level of patients available.
--enrollment expect to be fast..
--protocol optimized base on results of our CD12 and all EIND patients.
--Agencies like MHRA and others waiting for our interim results ,and possibly EUA..
So , within few months with excellent results we may have it , since interim in critical need only about 122 patients-40% of total of 306.
--We need just some final approval to start this trial..
Final Report in TNBC and evaluation of Basket trial...
--Final results should answer some questions regarding biomarkers analysis.
--Preliminary data was excellent , and final data expect only to improve , and right now we showing superiority to Gilead Trodelvy.
--Basket trial , patients testimonies foreshadowing an excellent report.
--All this open possibility of receiving BTD.
Interim NASH analysis.
--it is expected that CYDY will release interim results on 60 trial patients within days , weeks.
--NASH is the largest growing disease, probably surpassing LH in covid.
--No other drug effective in this disease is approved.
--Preclinical study with leronlimab done by Dr Lindner in Cleveland Clinic showed very positive results.
BLA Filing..
--Waiting for FDA opinion about filed papers with Dose Justification.
--Other reports are mostly done , so if no problem with this report , they may just accelerate the entire filing and " surprise everyone "
Long Hauler Phase 2b/3 Protocol.
--They may approach FDA for BTD
--Evaluating battery of blood samples now from our first patients.
--The LH data from phase 2 showed 18 out of 24 symptoms being relieved.
Filing CCR5 MOA Patents,
--With biomarker data coming , they observing witch patients tend to respond better.
--they also have a better clue about underlying MOA.
--These information will be very important before talking with BP.
--RANTES ( CCL5 ) seems to be an underlying theme linking these diseases , but what if it is more then rantes.
-" UNVEILLING this discovery make the world take notice "
So truly August might be a very exciting month for us.
And what an interesting drug it is , and ALL THIS without ONE serious side effect.
No wonder so many want to put their hands on it .
All IMO.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM